Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cardiotoxicity of doxorubicin-based cancer treatment: What is the protective cognition that phytochemicals provide us?
Cun Liu, Xiaoran Ma, Jing Zhuang, et al.
Pharmacological Research (2020) Vol. 160, pp. 105062-105062
Closed Access | Times Cited: 40

Showing 1-25 of 40 citing articles:

Doxorubicin conjugates: a practical approach for its cardiotoxicity alleviation
Abed Alqader Ibrahim, Hamdi Nsairat, Mazen Al-Sulaibi, et al.
Expert Opinion on Drug Delivery (2024) Vol. 21, Iss. 3, pp. 399-422
Closed Access | Times Cited: 9
Hollow mesoporous prussian blue nanozymes alleviate doxorubicin-induced cardiotoxicity by restraining oxidative stress associated with Nrf2 signaling
Fang Wang, Ke Wang, Baoru Fang, et al.
Journal of Colloid and Interface Science (2025) Vol. 686, pp. 1074-1088
Closed Access | Times Cited: 1
Involvement of Abnormal Gut Microbiota Composition and Function in Doxorubicin-Induced Cardiotoxicity
Jie Huang, Shanshan Wei, Chuanhao Jiang, et al.
Frontiers in Cellular and Infection Microbiology (2022) Vol. 12
Open Access | Times Cited: 31
Mesaconine alleviates doxorubicin-triggered cardiotoxicity and heart failure by activating PINK1-dependent cardiac mitophagy
Jichao Zhou, Cai‐Cai Jin, Xiao-Li Wei, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 20
The Battlefield of Chemotherapy in Pediatric Cancers
Letao Bo, Youyou Wang, Yidong Li, et al.
Cancers (2023) Vol. 15, Iss. 7, pp. 1963-1963
Open Access | Times Cited: 16
Role of Curcuma longae Rhizoma in medical applications: research challenges and opportunities
Peng Zhang, Hong Liu, Yu Yuan, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 7
Preparation of C@C3N4/IL/AuNPS as a sensitive electrochemical sensor for the determination of doxorubicin
Masoumeh Ghalkhani, Esmail Sohouli, Parvin Abedi Ghobadloo
Materials Research Bulletin (2024) Vol. 179, pp. 112930-112930
Closed Access | Times Cited: 6
Evaluation of the effect of Shengxian Decoction on doxorubicin-induced chronic heart failure model rats and a multicomponent comparative pharmacokinetic study after oral administration in normal and model rats
Cui-Yun Huang, Shi Qiu, Xiangcheng Fan, et al.
Biomedicine & Pharmacotherapy (2021) Vol. 144, pp. 112354-112354
Open Access | Times Cited: 33
Strategic developments in the drug delivery of natural product dihydromyricetin: applications, prospects, and challenges
Ruirui Zhang, Hao Zhang, Houyin Shi, et al.
Drug Delivery (2022) Vol. 29, Iss. 1, pp. 3052-3070
Open Access | Times Cited: 22
p53 at the Crossroads between Doxorubicin-Induced Cardiotoxicity and Resistance: A Nutritional Balancing Act
Yuanfang Guo, Yufeng Tang, Guangping Lu, et al.
Nutrients (2023) Vol. 15, Iss. 10, pp. 2259-2259
Open Access | Times Cited: 14
Synergistic effects of doxorubicin and coumarin on colorectal cancer cell proliferation and EMT modulation: in silico and in vitro study
Mahsa Khakparaghi, Majid Nejati, Atena Abed, et al.
Annals of Medicine and Surgery (2025) Vol. 87, Iss. 3, pp. 1271-1281
Open Access
Ginsenoside Rh2 regulates cardiomyocyte autophagy-dependent apoptosis through the PI3K-Akt-mTOR signaling pathway to attenuate doxorubicin-induced cardiotoxicity
Youping Wu, Sheng Zhang, Liqiang Gu, et al.
Applied Biological Chemistry (2025) Vol. 68, Iss. 1
Open Access
Molecular mechanisms and cardiovascular implications of cancer therapy-induced senescence
Ibrahim Y. Abdelgawad, Karim Thomas Sadak, Diana W. Lone, et al.
Pharmacology & Therapeutics (2020) Vol. 221, pp. 107751-107751
Open Access | Times Cited: 38
CYP1B1 as a therapeutic target in cardio-oncology
Alexa N. Carrera, Marianne Grant, Beshay N. Zordoky
Clinical Science (2020) Vol. 134, Iss. 21, pp. 2897-2927
Open Access | Times Cited: 32
Anti-inflammatory, antioxidant, antihypertensive, and antiarrhythmic effect of indole-3-carbinol, a phytochemical derived from cruciferous vegetables
Natalia Jorgelina Prado, Daniela Ramírez, Luciana Mazzei, et al.
Heliyon (2022) Vol. 8, Iss. 2, pp. e08989-e08989
Open Access | Times Cited: 19
TLR2 activates AP‐1 to facilitate CTGF transcription and stimulate doxorubicin‐induced myocardial injury
Lang Hong, Xinyong Cai, Yuliang Zhan, et al.
British Journal of Pharmacology (2025)
Open Access
Sonochemical preparation of folate-decorated reductive-responsive carboxymethylcellulose-based nanocapsules for targeted drug delivery
Shihao He, Shuangling Zhong, Qingye Meng, et al.
Carbohydrate Polymers (2021) Vol. 266, pp. 118174-118174
Closed Access | Times Cited: 24
α-Bisabolol, a Dietary Sesquiterpene, Attenuates Doxorubicin-Induced Acute Cardiotoxicity in Rats by Inhibiting Cellular Signaling Pathways, Nrf2/Keap-1/HO-1, Akt/mTOR/GSK-3β, NF-κB/p38/MAPK, and NLRP3 Inflammasomes Regulating Oxidative Stress and Inflammatory Cascades
Mohamed Fizur Nagoor Meeran, Seenipandi Arunachalam, Sheikh Azimullah, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 18, pp. 14013-14013
Open Access | Times Cited: 10
Traditional Chinese medicine as a protective strategy against chemotherapy-induced cardiotoxicity: An overview of the literature
Junwei Wang, Hong Shao, You-Ni Zhang, et al.
Journal of Traditional and Complementary Medicine (2024) Vol. 15, Iss. 2, pp. 107-118
Open Access | Times Cited: 3
Cardioprotective Roles of β-Hydroxybutyrate Against Doxorubicin Induced Cardiotoxicity
Yihai Liu, Xuan Wei, Mingyue Wu, et al.
Frontiers in Pharmacology (2021) Vol. 11
Open Access | Times Cited: 21
Hydroxytyrosol Prevents Doxorubicin-Induced Oxidative Stress and Apoptosis in Cardiomyocytes
Ivana Sirangelo, Maria Liccardo, Clara Iannuzzi
Antioxidants (2022) Vol. 11, Iss. 6, pp. 1087-1087
Open Access | Times Cited: 15
A systematic study on the treatment of hepatitis B-related hepatocellular carcinoma with drugs based on bioinformatics and key target reverse network pharmacology and experimental verification
Shenghao Li, Liyuan Hao, Xiaoyu Hu, et al.
Infectious Agents and Cancer (2023) Vol. 18, Iss. 1
Open Access | Times Cited: 8
Oxymatrine Synergistically Enhances Doxorubicin Anticancer Effects in Colorectal Cancer
Di Pan, Wen Zhang, Nenling Zhang, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 18
Role of gut microbiota in doxorubicin-induced cardiotoxicity: from pathogenesis to related interventions
Chao Huang, Xiaoxia Li, Hanqing Li, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 2
Induction of P-glycoprotein expression by dandelion in tumor and heart tissues: Impact on the anti-tumor activity and cardiotoxicity of doxorubicin
Jiameng Qu, Fan Ke, Xiao Yang, et al.
Phytomedicine (2022) Vol. 104, pp. 154275-154275
Closed Access | Times Cited: 9
Page 1 - Next Page

Scroll to top